-
Shadow over Vonn as Shiffrin, Odermatt headline Olympic skiing
-
US seeks minerals trade zone in rare Trump move with allies
-
Ukraine says Abu Dhabi talks with Russia 'substantive and productive'
-
Brazil mine disaster victims in London to 'demand what is owed'
-
AI-fuelled tech stock selloff rolls on
-
Russia vows to act 'responsibly' as nuclear pact ends with US
-
White says time at Toulon has made him a better Scotland player
-
Washington Post announces 'painful' job cuts
-
All lights are go for Jalibert, says France's Dupont
-
Artist rubs out Meloni church fresco after controversy
-
Palestinians in Egypt torn on return to a Gaza with 'no future'
-
US removing 700 immigration officers from Minnesota
-
Who is behind the killing of late ruler Gaddafi's son, and why now?
-
Coach Thioune tasked with saving battling Bremen
-
Russia vows to act 'responsibly' once nuclear pact with US ends
-
Son of Norway's crown princess admits excesses but denies rape
-
US calls for minerals trade zone in rare move with allies
-
Vowles dismisses Williams 2026 title hopes as 'not realistic'
-
'Dinosaur' Glenn chasing skating gold in first Olympics
-
Gaza health officials say strikes kill 23 after Israel says shots wounded officer
-
Italy foils Russian cyberattacks targeting Olympics
-
Stocks stabilise after Wall St AI-fuelled sell-off
-
Figure skating favourite Malinin feeling 'the pressure' in Milan
-
Netflix film probes conviction of UK baby killer nurse
-
Timber hopes League Cup can be catalyst for Arsenal success
-
China calls EU 'discriminatory' over probe into energy giant Goldwind
-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
Can Vonn defy ACL rupture to win Olympic medal?
-
Breakthrough or prelude to attack? What we know about Iran-US talks
-
German far-right MP detained over alleged Belarus sanctions breach
-
MSF says its hospital in South Sudan hit by government air strike
-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
-
Gaza health officials say strikes kill 21 after Israel says shots wounded officer
-
Injured Vonn's Olympic bid is 'inspirational', ski stars say
-
Albania arrests 20 for toxic waste trafficking
-
US-Africa trade deal renewal only 'temporary breather'
-
Mir sets pace on Sepang day two, Yamaha absent
-
Xi, Putin hail 'stabilising' China-Russia alliance
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Sky is the limit for Ireland fly-half Prendergast, says captain Doris
-
Stocks fluctuate after Wall St AI-fuelled sell-off
-
Feyi-Waboso reminds England great Robinson of himself
-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
Bausch Health to Announce Third Quarter 2025 Results on October 29
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
W.Nelson--AT